rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
CADILA HEALTHCARE LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Download announcement < Back
13 Dec 2021
Zydus to begin Phase II (a) clinical trial of ZYIL1, a novel oral NLRP3 inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome (CAPS) in Australia
View all announcements for CADILA HEALTHCARE LTD. Source: BSE India